Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Prometheus Biosciences To Be Acquired By Merck
(RTTNews) – In a bid to strengthen its immunology pipeline, Merck (MRK) has agreed to acquire Prometheus Biosciences Inc. (RXDX) for $200.00 per share in
Merck in Late-Stage Talks to Acquire Prometheus Biosciences
Merck & Co. is in late-stage talks to acquire Prometheus Biosciences Inc., according to people familiar with the matter, a move that could give the
HC Wainwright & Co. Maintains Arcadia Biosciences (RKDA) Buy Recommendation
Fintel reports that on April 14, 2023, HC Wainwright & Co. maintained coverage of Arcadia Biosciences (NASDAQ:RKDA) with a Buy recommendation. Analyst Price Forecast Suggests
TD Cowen Upgrades Pacific Biosciences of California (PACB)
On March 31, 2023, TD Cowen upgraded their outlook for Pacific Biosciences of California (NASDAQ:PACB) from Market Perform to Outperform . Analyst Price Forecast Suggests
Avidity Biosciences Enters Oversold Territory (RNA)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to
Harmony Biosciences Holdings, Inc. (HRMY) Soars 8.3%: Is Further Upside Left in the Stock?
Harmony Biosciences Holdings, Inc. (HRMY) shares soared 8.3% in the last trading session to close at $33.36. The move was backed by solid volume with
Biotechnology Value Fund L P Now Owns 5.10% of Ideaya Biosciences (IDYA)
Fintel reports that Biotechnology Value Fund L P has filed a 13G form with the SEC disclosing ownership of 2.46MM shares of Ideaya Biosciences Inc